- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Childhood Sexual Abuse Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Restructuring and Business Bankruptcy
- Wealth Planning, Administration, and Disputes
- Litigation Support Services
-
February 14, 2020Robins Kaplan Recognized in 2020 World Trademark Review 1000
-
February 13, 2020Settlement Announced in Tribal Voting Identification and Ballot Access Case
-
February 7, 2020Los Angeles Attorneys Named to 2020 “Southern California Super Lawyers” List
-
February 18, 2020Antitrust Issues in Agriculture with Minnesota Attorney General Keith Ellison
-
February 20, 2020Judicial Law Clerk Meet and Greet
-
February 21, 2020The Black BigLaw Pipeline Networking Reception
-
February 11, 2020INSIGHT: California’s Rebuke of Forced Arbitration in Limbo, Full of Uncertainty
-
February 7, 2020Colossus and Xactimate: A Tale of Two AI Insurance Software Programs
-
February 2020Have You Seen My Genes? Preconception Carrier Screening
Find additional firm contact information for press inquiries.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Purdue's Sleep Aid Patents Are Obvious, Judge Rules
March 30, 2015
Law360, New York (March 30, 2015, 3:01 PM ET) -- A New Jersey federal judge on Friday found that Purdue Pharmaceutical Products LP’s three patents for sleep aid Intermezzo are invalid for obviousness, granting a win to Actavis Elizabeth LLC, Novel Laboratories Inc. and others whom Purdue sued over plans to market their own generic versions of the drug.
All Content © 2003‐2015, Portfolio Media, Inc.
Law360
READ FULL ARTICLE Related Professionals
Jake M. Holdreith
Partner
Related Publications
Winter 2020
ANDA Approvals
GENERICally Speaking Winter 2020
Winter 2020
ANDA Litigation Settlements
GENERICally Speaking Winter 2020
Winter 2020
Generic Launches
GENERICally Speaking Winter 2020
Winter 2020
New ANDA Cases
GENERICally Speaking Winter 2020
January 10, 2020
Related News
June 17, 2019
November 8, 2018
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.